Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634094
What this trial is testing
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
Who this might be right for
Ovarian Cancer
Kalinski, Pawel, MD, PhD 28